M3 Total Revenue

M3 posts a total revenue of $280B as of June 2026. That compares with $310B in the prior-year period — down 10.2% year over year. That is above the Healthcare sector average of $110B. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, M3's total revenue was $310B. The latest reading is $280B — a 10.2% year-over-year decrease (period ending June 2026). Use the history and growth charts on this page for a longer lookback.

For Healthcare stocks, a total revenue near $110B is typical. M3's $280B is higher that level. That is roughly 152.8% above the sector mean. Whether that is a warning or an opportunity depends on growth outlook and other fundamentals shown elsewhere on Stockcircle.

Total Revenue is one piece of M3's financial statement story. At $280B, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for MTHRY's total revenue usually means three checks: (1) trend versus prior periods, (2) level versus peers (average $110B), and (3) consistency with growth and profitability. This page covers the first two; M3's other metric pages and overview cover the third.